View in EDS

BET Inhibition Enhances TNF-Mediated Antitumor Immunity.

Saved in:
Bibliographic Details
Title: BET Inhibition Enhances TNF-Mediated Antitumor Immunity.
Authors: Wellinger LC; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland., Hogg SJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Newman DM; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Friess T; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Geiss D; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Michie J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Ramsbottom KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Bacac M; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Zurich, Schlieren, Switzerland., Fauti T; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Zurich, Schlieren, Switzerland., Marbach D; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Jarassier L; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Thienger P; Department for BioMedical Research, University of Bern, Bern, Switzerland., Paehler A; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland., Cluse LA; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Kearney CJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Vervoort SJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Trapani JA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Oliaro J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Shortt J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Monash Haematology, Monash Health, Clayton, Australia.; School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Ruefli-Brasse A; Pfizer, South San Francisco, California., Rohle D; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland. drohle@ridgelinediscovery.com ricky.johnstone@petermac.org., Johnstone RW; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia. drohle@ridgelinediscovery.com ricky.johnstone@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
Source: Cancer immunology research [Cancer Immunol Res] 2022 Jan; Vol. 10 (1), pp. 87-107. Date of Electronic Publication: 2021 Nov 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34782346
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: BET Inhibition Enhances TNF-Mediated Antitumor Immunity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wellinger+LC%22">Wellinger LC</searchLink>; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hogg+SJ%22">Hogg SJ</searchLink>; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Newman+DM%22">Newman DM</searchLink>; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Friess+T%22">Friess T</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Geiss+D%22">Geiss D</searchLink>; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.<br /><searchLink fieldCode="AU" term="%22Michie+J%22">Michie J</searchLink>; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Ramsbottom+KM%22">Ramsbottom KM</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Bacac+M%22">Bacac M</searchLink>; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Zurich, Schlieren, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fauti+T%22">Fauti T</searchLink>; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Zurich, Schlieren, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marbach+D%22">Marbach D</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jarassier+L%22">Jarassier L</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Thienger+P%22">Thienger P</searchLink>; Department for BioMedical Research, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Paehler+A%22">Paehler A</searchLink>; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cluse+LA%22">Cluse LA</searchLink>; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Kearney+CJ%22">Kearney CJ</searchLink>; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Vervoort+SJ%22">Vervoort SJ</searchLink>; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Trapani+JA%22">Trapani JA</searchLink>; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Oliaro+J%22">Oliaro J</searchLink>; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Shortt+J%22">Shortt J</searchLink>; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Monash Haematology, Monash Health, Clayton, Australia.; School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Ruefli-Brasse+A%22">Ruefli-Brasse A</searchLink>; Pfizer, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Rohle+D%22">Rohle D</searchLink>; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland. drohle@ridgelinediscovery.com ricky.johnstone@petermac.org.<br /><searchLink fieldCode="AU" term="%22Johnstone+RW%22">Johnstone RW</searchLink>; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia. drohle@ridgelinediscovery.com ricky.johnstone@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2022 Jan; Vol. 10 (1), pp. 87-107. <i>Date of Electronic Publication: </i>2021 Nov 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34782346
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2326-6066.CIR-21-0224
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 87
    Titles:
      – TitleFull: BET Inhibition Enhances TNF-Mediated Antitumor Immunity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wellinger LC
      – PersonEntity:
          Name:
            NameFull: Hogg SJ
      – PersonEntity:
          Name:
            NameFull: Newman DM
      – PersonEntity:
          Name:
            NameFull: Friess T
      – PersonEntity:
          Name:
            NameFull: Geiss D
      – PersonEntity:
          Name:
            NameFull: Michie J
      – PersonEntity:
          Name:
            NameFull: Ramsbottom KM
      – PersonEntity:
          Name:
            NameFull: Bacac M
      – PersonEntity:
          Name:
            NameFull: Fauti T
      – PersonEntity:
          Name:
            NameFull: Marbach D
      – PersonEntity:
          Name:
            NameFull: Jarassier L
      – PersonEntity:
          Name:
            NameFull: Thienger P
      – PersonEntity:
          Name:
            NameFull: Paehler A
      – PersonEntity:
          Name:
            NameFull: Cluse LA
      – PersonEntity:
          Name:
            NameFull: Kearney CJ
      – PersonEntity:
          Name:
            NameFull: Vervoort SJ
      – PersonEntity:
          Name:
            NameFull: Trapani JA
      – PersonEntity:
          Name:
            NameFull: Oliaro J
      – PersonEntity:
          Name:
            NameFull: Shortt J
      – PersonEntity:
          Name:
            NameFull: Ruefli-Brasse A
      – PersonEntity:
          Name:
            NameFull: Rohle D
      – PersonEntity:
          Name:
            NameFull: Johnstone RW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6074
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer immunology research
              Type: main
ResultId 1